Document is current
Any future updates will be listed below
-
Authors
Heo, Keunjung
Ho, Tammy Szu-Yu
Zeng, Xiangsunze
Turnes, Bruna Lenfers
Arab, Maryam
Jayakar, Selwyn
Chen, Kuchuan
Kimourtzis, Georgios
Condro, Michael C.
Fazzari, Elisa
Song, Xuan
Tabitha Hees, J. https://orcid.org/0000-0001-6022-6907
Xu, Zhuqiu
Chen, Xirui
Barrett, Lee B.
Perrault, Laura
Pandey, Roshan
Zhang, Kathleen
Bhaduri, Aparna https://orcid.org/0000-0003-4625-6899
He, Zhigang https://orcid.org/0000-0001-6080-6880
Kornblum, Harley I. https://orcid.org/0000-0002-3779-4540
Hubbs, Jed https://orcid.org/0000-0002-3923-3392
Woolf, Clifford J. https://orcid.org/0000-0002-6636-3897
-
Funding
Funding for this research was provided by:
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R35NS105076,)
Spinal Muscular Atrophy Foundation
Ellen R. and Melvin J. Gordon Center for the Cure and Treatment of Paralysis Award
Ellen R. and Melvin J. Gordon Center for the Cure and Treatment of Paralysis Award Leonard and Isabelle Goldenson fellowship
- License Information
-
More Information
Article History
Received: 14 August 2024
Accepted: 14 March 2025
First Online: 26 March 2025
Competing interests
: C.J.W. is a founder of Nocion Therapeutics, QurAlis, and BlackBox Bio and is on the scientific advisory board of Lundbeck Pharma, Axonis, and Tafalgie Therapeutics. Z.H. is a co-founder of Rugen and Myrobalan, and an advisor of Axonis. The remaining authors declare no competing interests.
